Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.

[1]  L. Notarangelo,et al.  Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. , 2007, The Journal of allergy and clinical immunology.

[2]  J. Puck,et al.  Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. , 2007, Blood.

[3]  A. Gennery,et al.  Quantitative Assessment of Mixed Chimerism in Allogeneic Stem Cell Transplant Patients: A Comparison of Molecular Genetic and Cytogenetic Approaches , 2007, Journal of pediatric hematology/oncology.

[4]  A. Fischer,et al.  Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. , 2007, Blood.

[5]  A. Rolink,et al.  Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation , 2006, European journal of immunology.

[6]  F. Miedema,et al.  Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. , 2006, Blood.

[7]  T. Klingebiel,et al.  A Comparison between Three Graft Manipulation Methods for Haploidentical Stem Cell Transplantation in Pediatric Patients: Preliminary Results of a Pilot Study , 2005, Klinische Pädiatrie.

[8]  I. Shah.  Severe combined immunodeficiency. , 2005, Indian pediatrics.

[9]  Kathryn L. Parsley,et al.  Failure of SCID-X1 gene therapy in older patients. , 2005, Blood.

[10]  A. Fenton,et al.  Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry , 2005, Clinical and experimental immunology.

[11]  M. Slatter,et al.  Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency , 2005, Bone Marrow Transplantation.

[12]  A. Fischer,et al.  Severe combined immunodeficiency. A model disease for molecular immunology and therapy , 2005, Immunological reviews.

[13]  T. Cheetham,et al.  Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning , 2004, Bone Marrow Transplantation.

[14]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[15]  G. Spickett,et al.  Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies , 2003, Bone Marrow Transplantation.

[16]  A. Fischer,et al.  Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.

[17]  P. Chiusolo,et al.  Immune reconstitution after autologous selectedperipheral blood progenitor cell transplantation:comparison of two CD34+ cell‐selection systems , 2001, Transfusion.

[18]  G. Spickett,et al.  CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center. , 2001, Cytotherapy.

[19]  J. Ziegler,et al.  Reduced memory B‐cell populations in boys with B‐cell dysfunction after bone marrow transplantation for X‐linked severe combined immunodeficiency , 2001, British journal of haematology.

[20]  T. A. Hewett,et al.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. , 2001, Experimental hematology.

[21]  S. Müller,et al.  Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation. , 2000, Blood.

[22]  E. Mazzolari,et al.  Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. , 2000, Haematologica.

[23]  P. Veys,et al.  Intrinsic defects of B cell function in X‐linked severe combined immunodeficiency , 2000, European journal of immunology.

[24]  A. Fischer,et al.  Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. , 1999, Blood.

[25]  J. Roberts,et al.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.

[26]  A. Fischer,et al.  Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. , 1998, Blood.

[27]  M. Abinun,et al.  In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID) , 1997, Bone Marrow Transplantation.

[28]  C. Morimoto,et al.  P. Rambotti Lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets. , 1993, Clinical and experimental rheumatology.